Scarica l'app Stockscreener
7.625
1.27%
0.115
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Rxsight Inc Borsa (RXST) Ultime notizie
Building trade automation scripts for RxSight Inc.2025 Major Catalysts & Verified Momentum Stock Alerts - newser.com
Combining price and volume data for RxSight Inc.Weekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
RxSight Inc. stock trend forecast2025 Trading Volume Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Lacklustre Performance Is Driving RxSight, Inc.'s (NASDAQ:RXST) 25% Price Drop - simplywall.st
RxSight Inc. stock trend outlook and recovery pathStock Surge & Weekly High Return Stock Opportunities - newser.com
When is the best time to exit RxSight Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is RxSight Inc. stock bottoming out2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Candlestick signals on RxSight Inc. stock todayWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
RxSight's (RXST) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Full technical analysis of RxSight Inc. stock2025 Major Catalysts & Daily Volume Surge Trade Alerts - newser.com
What data driven models say about RxSight Inc.’s futureGap Down & Fast Moving Stock Watchlists - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages RxSight, Inc. (RXST) Investors to Inquire about Securities Investigation - ACCESS Newswire
Can RxSight Inc. stock outperform in 2025 bull marketJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
How moving averages guide RxSight Inc. tradingPortfolio Update Report & Free Risk Controlled Daily Trade Plans - newser.com
Can volume confirm reversal in RxSight Inc.Stop Loss & Capital Efficient Trade Techniques - newser.com
Trend analysis for RxSight Inc. this week2025 Growth vs Value & Long-Term Growth Plans - newser.com
Is RxSight Inc. stock entering bullish territory2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Is RxSight Inc a good long term investmentSwing Trading Ideas & Investment Recommendations You Can Trust - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Investors to Reach Out - ACCESS Newswire
What drives RxSight Inc stock priceTop Performing Stocks & Outstanding Investment Returns - earlytimes.in
Head to Head Contrast: Monogram Orthopaedics (NASDAQ:MGRM) versus RxSight (NASDAQ:RXST) - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against RxSight, Inc. (RXST) And Encourages Stockholders to Reach Out - ACCESS Newswire
RxSight Inc Stock Analysis and ForecastTrend Following Strategies & Minimal Investment Portfolio - earlytimes.in
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Stockholders to Connect - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - PR Newswire
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat
RxSight, Inc. (NASDAQ:RXST) Receives Average Recommendation of “Reduce” from Brokerages - Defense World
Shareholders of RxSight, Inc. Should Contact Levi & - GlobeNewswire
RXSIGHT FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
Shareholders of RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to - Bluefield Daily Telegraph
0.23%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):